They proposed that combining PI3K/AKT pathway inhibitors with radiotherapy could improve the prognosis of ESCC patients, highlighting the close relationship between the PI3K/AKT signaling pathway and radiotherapy efficacy in ESCC. Here, AKT1 is linked to esophageal squamous cell carcinoma.